Japan Approves Dupixent for Bullous Pemphigoid Treatment
Japan’s Ministry of Health, Labour and Welfare has granted marketing and manufacturing authorization for Dupixent (dupilumab) for the treatment of adults with moderate-to-severe bullous…
Read More...
Read More...
